亿胜生物科技(01061)发布中期业绩 期内溢利1.63亿港元 同比增加3.79%

Core Viewpoint - The company reported a revenue of HKD 877 million for the six months ending June 30, 2025, representing a year-on-year increase of 5.79% [1] - The net profit for the same period was HKD 163 million, reflecting a year-on-year growth of 3.79% [1] - The basic earnings per share were HKD 0.2882, and the company proposed an interim dividend of HKD 0.07 per share [1] Financial Performance - Revenue reached HKD 877 million, up 5.79% compared to the previous year [1] - Net profit amounted to HKD 163 million, an increase of 3.79% year-on-year [1] - Basic earnings per share were reported at HKD 0.2882 [1] Dividend Announcement - The company plans to distribute an interim dividend of HKD 0.07 per share [1]